A molecule selected from a library of compounds that have structures similar to natural products targets several stages of the malarial parasite's life cycle, offering single-dose treatment of the disease in mouse models. See Article p.344
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
WHO. World Malaria Report 2015 www.who.int/malaria/publications/world-malaria-report-2015/report/en (2015).
Kato, N. et al. Nature 538, 344–349 (2016).
Ashley, E. A. et al. N. Engl. J. Med. 371, 411–423 (2014).
Leang, R. et al. Antimicrob. Ag. Chemother. 59, 4719–4726 (2015).
Lowe, J. T. et al. J. Org. Chem. 77, 7187–7211 (2012).
Wells, T. N. C., Hooft van Huijsduijnen, R. & Van Voorhis, W. C. Nature Rev. Drug Discov. 14, 424–442 (2015).
Pham, J. S. et al. Int. J. Parasitol. Drugs Drug Res. 4, 1–13 (2014).
Corey, V. C. et al. Nature Commun. 7, 11901 (2016).
Baragaña, B. et al. Nature 522, 315–320 (2015).
Phillips, M. A. et al. Sci. Transl. Med. 7, 296ra111 (2015).
Related links in Nature Research
About this article
Cite this article
Fidock, D. Chemical diversity targets malaria. Nature 538, 323–325 (2016). https://doi.org/10.1038/nature19481